European Organisation for Research and Treatment of Cancer Brain Tumor and Radiotherapy Groups; National Cancer Institute of Canada Clinical Trials Group Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma, N Engl J Med, vol.352, pp.987-996, 2005. ,
Hypoxia and the hypoxia-inducible-factor pathway in glioma growth and angiogenesis, Neuro Oncol, vol.7, pp.134-153, 2005. ,
VEGF promotes proliferation of human glioblastoma multiforme stem-like cells through VEGF receptor 2, ScientificWorldJournal, p.417413, 2013. ,
Functional significance of vascular endothelial growth factor receptor expression on human glioma cells, J Neurooncol, vol.67, pp.9-18, 2004. ,
Expression of VEGF and its receptors in different brain tumors, Neurol Res, vol.27, pp.371-377, 2005. ,
Mediators of glioblastoma resistance and invasion during antivascular endothelial growth factor therapy, Clin Cancer Res, vol.15, pp.4589-4599, 2009. ,
MGMT modulates glioblastoma angiogenesis and response to the tyrosine kinase inhibitor sunitinib, Neuro Oncol, vol.12, pp.822-833, 2010. ,
Bevacizumab alone and in combination with irinotecan in recurrent glioblastoma, J Clin Oncol, vol.27, pp.4733-4740, 2009. ,
FDA accelerated approval benefits glioblastoma, Lancet Oncol, vol.11, p.1120, 2010. ,
A review of VEGF/VEGFR-targeted therapeutics for recurrent glioblastoma, J Natl Compr Canc Netw, vol.9, pp.414-427, 2011. ,
Progression-free survival (PFS) and health-related quality of life (HRQoL) in AVAglio, a phase III study of bevacizumab (Bv), temozolomide (T), and radiotherapy (RT) in newly diagnosed glioblastoma (GBM), J Clin Oncol, 2013. ,
Phase II study of cediranib, an oral pan-vascular endothelial growth factor receptor tyrosine kinase inhibitor, in patients with recurrent glioblastoma, J Clin Oncol, vol.28, pp.2817-2823, 2010. ,
Phase III randomized trial comparing the efficacy of cediranib as monotherapy, and in combination with lomustine, versus lomustine alone in patients with recurrent glioblastoma, J Clin Oncol, vol.31, pp.3212-3218, 2013. ,
Updated response assessment criteria for high-grade gliomas: response assessment in neuro-oncology working group, J Clin Oncol, vol.28, pp.1963-1972, 2010. ,
Glioma grading: sensitivity, specificity, and predictive values of perfusion MR imaging and proton MR spectroscopic imaging compared with conventional MR imaging, AJNR Am J Neuroradiol, vol.24, pp.1989-1998, 2003. ,
Glioblastoma-derived tumor cells induce vasculogenic mimicry through Flk-1 protein activation, J Biol Chem, vol.287, pp.24821-24831, 2012. ,
Quantitative HRMAS proton total correlation spectroscopy applied to cultured melanoma cells treated by chloroethyl nitrosourea: demonstration of phospholipid metabolism alterations, Magn Reson Med, vol.49, pp.241-248, 2003. ,
Metabolic profiling, metabolomic and metabonomic procedures for NMR spectroscopy of urine, plasma, serum and tissue extracts, Nat Protoc, vol.2, pp.2692-2703, 2007. ,
Cell culture metabolomics: applications and future directions, Drug Discov Today, vol.15, pp.610-621, 2010. ,
Metabolomic profiling with NMR discriminates between biphosphonate and doxorubicin effects on B16 melanoma cells, NMR Biomed, vol.23, pp.1009-1016, 2010. ,
URL : https://hal.archives-ouvertes.fr/hal-00609861
Optimizing high-throughput metabolomic biomarker screening: a study of quenching solutions to freeze intracellular metabolism in CHO cells, OMICS, vol.16, pp.90-97, 2012. ,
Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays, J Immunol Methods, vol.65, pp.55-63, 1983. ,
NMRPipe: a multidimensional spectral processing system based on UNIX pipes, J Biomol NMR, vol.6, pp.277-293, 1995. ,
Orthogonal Projections to Latent Structures, J Chemometrics, vol.16, pp.119-128, 2002. ,
Autocrine regulation of glioblastoma cell cycle progression, viability and radioresistance through the VEGF-VEGFR2 (KDR) interplay, Cell Cycle, vol.7, pp.2553-2561, 2008. ,
Bevacizumab can induce reactivity to VEGF-C and -D in human brain and tumour derived endothelial cells, J Neurooncol, vol.104, pp.103-112, 2011. ,
Autocrine VEGF-VEGFR2-Neuropilin-1 signaling promotes glioma stem-like cell viability and tumor growth, J Exp Med, vol.209, pp.507-520, 2012. ,
Bevacizumab has differential and dose-dependent effects on glioma blood vessels and tumor cells, Clin Cancer Res, vol.17, pp.6192-6205, 2011. ,
Anti-VEGF treatment reduces blood supply and increases tumor cell invasion in glioblastoma, Proc Natl Acad Sci U S A, vol.108, pp.3749-3754, 2011. ,
Inhibition of glioma angiogenesis and growth in vivo by systemic treatment with a monoclonal antibody against vascular endothelial growth factor receptor-2, Cancer Res, vol.61, pp.6624-6628, 2001. ,
Antiangiogenic therapy elicits malignant progression of tumors to increased local invasion and distant metastasis, Cancer Cell, vol.15, pp.220-231, 2009. ,
Radiographic patterns of relapse in glioblastoma, J Neurooncol, vol.101, pp.319-323, 2011. ,
Bevacizumab does not increase the risk of remote relapse in malignant glioma, Ann Neurol, vol.69, pp.586-592, 2011. ,
Assignment of 1H nuclear magnetic resonance visible polyunsaturated fatty acids in BT4C gliomas undergoing ganciclovir-thymidine kinase gene therapyinduced programmed cell death, Cancer Res, vol.63, pp.3195-3201, 2003. ,
Highresolution magic angle spinning 1H NMR spectroscopy and reverse transcription-PCR analysis of apoptosis in a rat glioma, Anal Chem, vol.78, pp.1546-1552, 2006. ,
Increased unsaturation of lipids in cytoplasmic lipid droplets in DAOY cancer cells in response to cisplatin treatment, Metabolomics, vol.9, pp.722-729, 2013. ,
Nuclear magnetic resonance-visible lipids induced by cationic lipophilic chemotherapeutic agents are accompanied by increased lipid droplet formation and damaged mitochondria, Cancer Res, vol.62, pp.1394-1400, 2002. ,
Lipid biomarkers of glioma cell growth arrest and cell death detected by 1 H magic angle spinning MRS, NMR Biomed, vol.25, pp.1253-1262, 2012. ,
In Vitro and In Vivo Analysis of RTK Inhibitor Efficacy and Identification of Its Novel Targets in Glioblastomas, Transl Oncol, vol.6, pp.187-196, 2013. ,
Metabolite changes in BT4C rat gliomas undergoing ganciclovir-thymidine kinase gene therapy-induced programmed cell death as studied by 1H NMR spectroscopy in vivo, ex vivo, and in vitro, J Biol Chem, vol.278, pp.45915-45923, 2003. ,
Vascular endothelial growth factor (VEGF) and its receptors, FASEB J, vol.13, pp.9-22, 1999. ,
The splice variants of vascular endothelial growth factor (VEGF) and their receptors, J Cell Sci, vol.114, pp.853-865, 2001. ,
Capillary endothelial surface layer selectively reduces plasma solute distribution volume, Am J Physiol Heart Circ Physiol, vol.278, pp.285-289, 2000. ,
The effect of bevacizumab on human malignant melanoma cells with functional VEGF/ VEGFR2 autocrine and intracrine signaling loops, Neoplasia, vol.14, pp.612-623, 2012. ,
Metabolic response of glioblastoma to superselective intra-arterial cerebral infusion of bevacizumab: a proton MR spectroscopic imaging study, AJNR Am J Neuroradiol, vol.33, pp.2095-2102, 2012. ,
Magnetic resonance spectroscopy as an early indicator of response to anti-angiogenic therapy in patients with recurrent glioblastoma: RTOG 0625/ACRIN 6677, Neuro Oncol, vol.15, pp.936-944, 2013. ,
Serial magnetic resonance spectroscopy reveals a direct metabolic effect of cediranib in glioblastoma, Cancer Res, vol.71, pp.3745-3752, 2011. ,